Document is current
Any future updates will be listed below
-
Authors
Petruccioli, Elisa
Najafi Fard, Saeid
Navarra, Assunta
Petrone, Linda
Vanini, Valentina
Cuzzi, Gilda
Gualano, Gina
Pierelli, Luca
Bertoletti, Antonio
Nicastri, Emanuele
Palmieri, Fabrizio
Ippolito, Giuseppe
Goletti, Delia https://orcid.org/0000-0001-8360-4376
- License Information
-
More Information
Article History
Received: 2 April 2021
Accepted: 13 June 2021
First Online: 26 June 2021
Change Date: 16 March 2022
Change Type: Update
Change Details: Funding statement has been corrected.
Declarations
:
: This study was approved by the Ethical Committee of Lazzaro Spallanzani National Institute of Infectious Diseases (59/2020). Informed, written consent was required to prospectively enroll patients and controls by physicians. The study complied with the principles of the Declaration of Helsinki.
: Not applicable.
: AB submitted a patent to monitor SARS-Cov-2 specific T-cells and participated on advisory board for Oxford Immunotech and Quiagen; there are no conflicts of interest to declare for any of the other authors.
